These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 11034803)

  • 41. Detection of prolactin messenger RNA in mammary and other normal and neoplastic tissues by polymerase chain reaction.
    Fields K; Kulig E; Lloyd RV
    Lab Invest; 1993 Mar; 68(3):354-60. PubMed ID: 8450651
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Heterogeneous expression of MAGE-A genes in occult disseminated tumor cells: a novel multimarker reverse transcription-polymerase chain reaction for diagnosis of micrometastatic disease.
    Kufer P; Zippelius A; Lutterbüse R; Mecklenburg I; Enzmann T; Montag A; Weckermann D; Passlick B; Prang N; Reichardt P; Dugas M; Köllermann MW; Pantel K; Riethmüller G
    Cancer Res; 2002 Jan; 62(1):251-61. PubMed ID: 11782385
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bovine corpus luteum is an extrapituitary site of prolactin production.
    Shibaya M; Murakami S; Tatsukawa Y; Skarzynski DJ; Acosta TJ; Okuda K
    Mol Reprod Dev; 2006 Apr; 73(4):512-9. PubMed ID: 16435374
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aberrant expression of 5-lipoxygenase-activating protein (5-LOXAP) has prognostic and survival significance in patients with breast cancer.
    Jiang WG; Douglas-Jones AG; Mansel RE
    Prostaglandins Leukot Essent Fatty Acids; 2006 Feb; 74(2):125-34. PubMed ID: 16364620
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance.
    Apostolaki S; Perraki M; Kallergi G; Kafousi M; Papadopoulos S; Kotsakis A; Pallis A; Xenidis N; Kalmanti L; Kalbakis K; Agelaki S; Kalykaki A; Stournaras C; Stathopoulos E; Georgoulias V; Mavroudis D
    Breast Cancer Res Treat; 2009 Oct; 117(3):525-34. PubMed ID: 19016323
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Expression of nm23 in breast cancer: correlation with distant metastasis and prognosis].
    Liu H; Mao H; Fu X
    Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):224-7. PubMed ID: 11783092
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Value of reverse transcription polymerase chain assay in peripheral blood of patients with urothelial cancer.
    Okegawa T; Kinjo M; Nutahara K; Higashihara E
    J Urol; 2004 Apr; 171(4):1461-6. PubMed ID: 15017198
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [mRNA expression of CK19 and CEA in peripheral blood of patients with breast cancer detected by real-time quantitative PCR].
    Zheng HY; Chen Q; Ye YB; Huang WW
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2267-70. PubMed ID: 19087676
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Soluble VCAM-1 and E-selectin in breast cancer: relationship with staging and with the detection of circulating cancer cells.
    Silva HC; Garcao F; Coutinho EC; De Oliveira CF; Regateiro FJ
    Neoplasma; 2006; 53(6):538-43. PubMed ID: 17167725
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression and distribution of the prolactin receptor in normal rat liver and in experimental liver cirrhosis.
    Kloehn S; Otte C; Korsanke M; Arendt T; Clemens A; Glasow A; Bornstein SR; Fölsch UR; Mönig H
    Horm Metab Res; 2001 Jul; 33(7):394-401. PubMed ID: 11507675
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prolactin serum level in patients with breast cancer.
    Cohen AD; Cohen Y; Maislos M; Buskila D
    Isr Med Assoc J; 2000 Apr; 2(4):287-9. PubMed ID: 10804904
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prolactin synthesis and secretion by human breast cancer cells.
    Ginsburg E; Vonderhaar BK
    Cancer Res; 1995 Jun; 55(12):2591-5. PubMed ID: 7780973
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic value of estrogen and prolactin receptor analysis in human breast cancer.
    Waseda N; Kato Y; Imura H; Kurata M
    Jpn J Cancer Res; 1985 Jun; 76(6):517-23. PubMed ID: 2991064
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prolactin and oestrogen synergistically regulate gene expression and proliferation of breast cancer cells.
    Rasmussen LM; Frederiksen KS; Din N; Galsgaard E; Christensen L; Berchtold MW; Panina S
    Endocr Relat Cancer; 2010 Sep; 17(3):809-22. PubMed ID: 20601496
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of pyrimidine nucleoside phosphorylase mRNA plays an important role in the prognosis of patients with oesophageal cancer.
    Yamagata M; Mori M; Mimori K; Mafune KI; Tanaka Y; Ueo H; Akiyoshi T
    Br J Cancer; 1999 Feb; 79(3-4):565-9. PubMed ID: 10027331
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thyrotropin-releasing hormone and oestrogen differentially regulate prolactin and prolactin receptor expression in female human skin and hair follicles in vitro.
    Langan EA; Ramot Y; Hanning A; Poeggeler B; Bíró T; Gaspar E; Funk W; Griffiths CE; Paus R
    Br J Dermatol; 2010 May; 162(5):1127-31. PubMed ID: 20302576
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Circulating prolactin and tumoral prolactin receptors in men with tongue cancer: a preliminary study.
    Patel DD; Bhatavdekar JM; Vora HH; Balar DB
    Eur J Surg Oncol; 1994 Apr; 20(2):155-9. PubMed ID: 8181582
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PRO_10--a new tissue-based prognostic multigene marker in patients with early estrogen receptor-positive breast cancer.
    Moor AE; Guevara C; Altermatt HJ; Warth R; Jaggi R; Aebi S
    Pathobiology; 2011; 78(3):140-8. PubMed ID: 21613801
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical relevance of Ki67 gene expression analysis using formalin-fixed paraffin-embedded breast cancer specimens.
    Yamamoto S; Ibusuki M; Yamamoto Y; Fu P; Fujiwara S; Murakami K; Iwase H
    Breast Cancer; 2013 Jul; 20(3):262-70. PubMed ID: 22362219
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prolactin binding in benign and malignant mammary tissue of female dogs.
    Rutteman GR; Willekes-Koolschijn N; Bevers MM; Van der Gugten AA; Misdorp W
    Anticancer Res; 1986; 6(4):829-35. PubMed ID: 3019223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.